Ascentage Pharma Group International Earnings

Ascentage Pharma Group International’s revenue fell -71.63% since last year same period to $233.7Mn in the Q2 2025. On a quarterly growth basis, Ascentage Pharma Group International has generated 48.94% jump in its revenue since last 3-months.

Ascentage Pharma Group International’s net profit fell -462.43% since last year same period to $-590.77Mn in the Q2 2025. On a quarterly growth basis, Ascentage Pharma Group International has generated -3.93% fall in its net profits since last 3-months.

Ascentage Pharma Group International’s net profit margin fell -1377.5% since last year same period to -252.79% in the Q2 2025. On a quarterly growth basis, Ascentage Pharma Group International has generated 30.22% jump in its net profit margins since last 3-months.

Ascentage Pharma Group International’s earning per share (EPS) estimates for the current quarter stand at 0 - a 100% jump from last quarter’s estimates.

Ascentage Pharma Group International’s earning per share (EPS) estimates for the current year stand at 0.

Ascentage Pharma Group International’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Ascentage Pharma Group International has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.